Live Cell Imaging Market Size To Reach $4.49 Billion By 2030

Live Cell Imaging Market Growth & Trends

The global live cell imaging market size is expected to reach USD 4.49 billion by 2030, as per a new report by Grand View Research Inc., expanding at a CAGR of 8.9% from 2024 to 2030. The rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.

In a survey by Drug Discovery World Spring, almost 21% of researchers prefer & use live cell imaging, and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.

Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased the use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.

 Request a free sample copy or view report summary: Live Cell Imaging Market Report

Live Cell Imaging Market Report Highlights

• The equipment segment dominated the market with 56.2% share in 2023. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.

• The stem cell & drug discovery segment dominated the market with 46.1% share in 2023. This is mainly due to the increasing demand for advanced imaging techniques that allow researchers to observe cellular processes in real-time.

• The developmental biology segment is projected to grow at a CAGR of 7.7% over the forecast period due to the use of live cell imaging in observation of cell embryogenesis and to study the physiological state of the cell.

• North America dominated the global market with 36.6% share in 2023. The growth in this region is due to various factors such as increasing number of investments in research and development in market.

Live Cell Imaging Market Segmentation

Grand View Research has segmented the global live cell imaging market on the basis of product, application, technology and region: 

Live Cell Imaging Product Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment

• Consumable

• Software

Live Cell Imaging Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cell Biology

• Developmental Biology

• Stem Cell & Drug Discovery

• Others

Live Cell Imaging Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Time lapse Microscopy

• Fluorescence recovery after photobleaching (FRAP)

• Fluorescence resonance energy transfer (FRET)

• High content screening (HCS)

• Others

Live Cell Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East And Africa (MEA)

  • UAE

  • South Arabia

  • South Africa

  • Kuwait

List of Key Players in the Live Cell Imaging Market

• Nikon Corporation

• Carl Zeiss AG

• GE HealthCare.

• PerkinElmer

• Leica Microsystems

• Olympus Corporation

• Biotech Instruments Inc.

• Thermo Fisher Scientific Inc.

• CYTENA GmbH

• Corning Incorporated

• Bruker